<DOC>
	<DOCNO>NCT00002024</DOCNO>
	<brief_summary>To provide ganciclovir compassionate use basis immunocompromised patient serious cytomegalovirus ( CMV ) infection study safety efficacy patient population .</brief_summary>
	<brief_title>Ganciclovir : Compassionate Use Patients With Serious Life-Threatening Cytomegalovirus Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Topical acyclovir . Exclusion Criteria Coexisting Condition : Patients follow exclude : Mild moderate cytomegalovirus ( CMV ) infection fail satisfy clinical severity criterion . Transplant trial reduction immunosuppressive drug treatment feasible . Congenital neonatal CMV infection document congenital acquire immunodeficiency . Neutropenia unless preexist . Thrombocytopenia unless preexist . Concurrent Medication : Excluded : Other myelosuppressive drug cancer chemotherapy agent , interferon , foscarnet , nucleoside analog . Patients follow exclude : Mild moderate cytomegalovirus ( CMV ) infection fail satisfy clinical severity criterion . Transplant trial reduction immunosuppressive drug treatment feasible . Congenital neonatal CMV infection document congenital acquire immunodeficiency . Neutropenia unless preexist . Thrombocytopenia unless preexist . Patients must immunocompromised serious cytomegalovirus ( CMV ) infection . This would include pneumonia , gastrointestinal disease , hepatitis , organspecific disease severe waste syndrome . Patients preexist neutropenia thrombocytopenia , immediate lifethreatening disease include investigator believe delay start ganciclovir therapy advisable . In patient , investigator must advise patient risk marrow suppression increase risk infection bleeding ; patient must sign amend informed consent form .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Immune Tolerance</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Drugs , Investigational</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>